Pericytes contribute to airway remodeling in a mouse model of chronic allergic asthma

Jill R Johnson1, Erika Folestad2, Jessica E Rowley3

  • 1Department of Medical Biochemistry and Biophysics, Matrix Division, Division of Vascular Biology, Karolinska Institutet, Stockholm, Sweden; Leukocyte Biology Section, National Heart and Lung Institute, Sir Alexander Fleming Building, Imperial College London, London, United Kingdom; and jill.johnson@imperial.ac.uk.

Insights

In chronic asthma, inhibiting PDGFRβ signaling worsened lung dysfunction and airway thickening. This suggests PDGF-BB/PDGFRβ signaling and pericyte accumulation contribute to airway remodeling.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Cell Biology

Background:

  • Chronic asthma involves myofibroblast accumulation, subepithelial fibrosis, and vascular remodeling, with unclear mechanisms.
  • Platelet-derived growth factors (PDGFs) are implicated in lung fibrosis, but their role in asthma airway remodeling is unknown.
  • PDGF-BB signaling via PDGFRβ is crucial for pericyte recruitment, but its function in asthma is not established.

Purpose of the Study:

  • To investigate the role of PDGFRβ signaling in airway remodeling and lung dysfunction in a mouse model of chronic allergic asthma.
  • To determine if inhibiting PDGFRβ signaling affects airway remodeling and lung function in established asthma.

Main Methods:

  • Utilized a selective PDGFRβ inhibitor (CP-673451) in a house dust mite-induced chronic allergic asthma mouse model.
  • Assessed lung dysfunction, airway smooth muscle thickness, and inflammatory responses.
  • Examined PDGF-BB expression, pericyte markers, and their localization in airway tissues.

Main Results:

  • Unexpectedly, PDGFRβ inhibition exacerbated lung dysfunction and airway smooth muscle thickening in asthmatic mice.
  • Aeroallergen challenge led to decreased PDGF-BB expression and pericyte loss from airway microvasculature.
  • Pericyte marker-positive cells accumulated in the subepithelial region, a process worsened by PDGFRβ inhibition.

Conclusions:

  • Perturbed PDGF-BB/PDGFRβ signaling contributes to airway remodeling in chronic allergic asthma.
  • Pericyte accumulation in the airway wall is linked to asthma pathogenesis.
  • Targeting PDGFRβ signaling may have complex effects on asthma progression.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
2
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
2
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K